If your email program has trouble displaying this email, view as a webpage. Recently Posted Guidance Documents 2/9/2022 - Guidance for Industry: Questions and Answers Regarding Channels of Trade Policy for Human Food Commodities with Chlorpyrifos Residues 2/9/2022 - Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry: Draft Guidance for Industry 2/8/2022 - COVID-19 Public Health Emergency Policy on COVID-19-Related Sanitation Tunnels: Guidance for Industry and Investigators 2/7/2022 - Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Draft Guidance for Industry Guidance Document Search Search all FDA official guidance documents and other regulatory guidance

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA